View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Rheumatoid Arthritis News

SPONSORED CONTENT
Save
SPONSORED CONTENT
March 05, 2024
2 min read
Save

Depression risk elevated in both seropositive, seronegative rheumatoid arthritis

Depression risk elevated in both seropositive, seronegative rheumatoid arthritis

Patients with rheumatoid arthritis — either seropositive or seronegative — demonstrate a 1.66-fold higher risk for depression vs. healthy controls, according to data published in JAMA Network Open.

SPONSORED CONTENT
March 01, 2024
1 min read
Save

FDA approves Acthar Gel SelfJect injector in autoimmune, inflammatory conditions

FDA approves Acthar Gel SelfJect injector in autoimmune, inflammatory conditions

The FDA has approved a supplemental new drug application for an Acthar Gel injector for the treatment of several chronic and acute inflammatory and autoimmune conditions, according to the manufacturer.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
February 28, 2024
1 min read
Save

Six biomarkers could predict CVD risk in patients with rheumatoid arthritis

Six biomarkers could predict CVD risk in patients with rheumatoid arthritis

Six biomarkers were associated with baseline and treatment-associated changes in arterial inflammation in patients with rheumatoid arthritis and could be used to predict CVD risk in that population, researchers reported.

SPONSORED CONTENT
February 26, 2024
2 min read
Save

FDA approves Simlandi as third interchangeable Humira biosimilar

FDA approves Simlandi as third interchangeable Humira biosimilar

The FDA has approved Simlandi as the third interchangeable biosimilar to Humira following a rejection in April 2023 stemming from issues at the developer’s manufacturing facility.

SPONSORED CONTENT
February 26, 2024
3 min read
Save

Rheumatology meets placebo-nocebo science: At last!

Rheumatology meets placebo-nocebo science: At last!

I am thrilled to introduce our cover story this month, “‘Exploring the Power of Their Mind’: Data May Offer Clues to Harnessing the Placebo Effect,” to the readers of Healio Rheumatology. I say this for several reasons.

SPONSORED CONTENT
February 23, 2024
2 min read
Save

Wnt, neutrophil extracellular traps emerging as ‘important’ rheumatoid arthritis targets

Wnt, neutrophil extracellular traps emerging as ‘important’ rheumatoid arthritis targets

SCOTTSDALE, Ariz. — The Wnt signaling pathway, neutrophil extracellular traps and PRIME cells represent “extremely important” emerging targets in rheumatoid arthritis, according to a speaker here.

SPONSORED CONTENT
February 20, 2024
1 min read
Save

US Veterans Affairs to replace Humira with biosimilar on national formulary

US Veterans Affairs to replace Humira with biosimilar on national formulary

The U.S. Department of Veterans Affairs will replace Humira with the biosimilar Hadlima on its national formulary, according to a press release from Organon, which markets biosimilar.

SPONSORED CONTENT
February 19, 2024
2 min read
Save

‘Double negative’ B cells may predict abatacept response in rheumatoid arthritis

‘Double negative’ B cells may predict abatacept response in rheumatoid arthritis

SCOTTSDALE, Ariz. — Patients with rheumatoid arthritis who had a decrease in a certain type of B cell that fails to express immunoglobulin D and CD27 saw clinical improvement with abatacept, according to data presented here.

SPONSORED CONTENT
February 15, 2024
2 min read
Save

Gut microbiome dictates DMARD response in RA; DMARDs partly restore microbiota diversity

Gut microbiome dictates DMARD response in RA; DMARDs partly restore microbiota diversity

Gut microbiota profiles in stool samples of patients with rheumatoid arthritis predicted their response to disease-modifying antirheumatic drugs, according to data in Rheumatology.

SPONSORED CONTENT
February 14, 2024
2 min read
Save

Biologic DMARD usage almost flat since 2008 among patients with RA, breast cancer

Biologic DMARD usage almost flat since 2008 among patients with RA, breast cancer

Among patients with rheumatoid arthritis diagnosed with breast cancer, the utilization of TNF inhibitors and other biologic disease-modifying antirheumatic drugs has not risen for more than a decade, according to data published in Arthritis Care & Research.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails